Jin Sheng Hongming Pan Weidong Han
10.3389/fimmu.2023.1181444
Front Immunol
2023 Apr 19;14:1181444.
cancer of unknown primary case report gene expression profiling immunochemotherapy metastatic adenocarcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/37153561/
Adenocarcinoma / drug therapy Adenocarcinoma / therapy Neoplasms, Unknown Primary / drug therapy Neoplasms, Unknown Primary / therapy
Adenocarcinoma / drug therapy Adenocarcinoma / therapy Neoplasms, Unknown Primary / drug therapy Neoplasms, Unknown Primary / therapy Review Case Reports Research Support, Non-U.S. Gov't B7-H1 Antigen / metabolism Female Gene Expression Profiling Humans Immunotherapy / methods Middle Aged Nivolumab / therapeutic use Nivolumab B7-H1 Antigen
PMC10154565
37153561
Immunochemotherapy achieved a complete response for metastatic adenocarcinoma of unknown primary based on gene expression profiling: a case report and review of the literature
2023